Concepedia

Giovanni Della Cioppa

GD

46

Publications

5.8K

Citations

32

H-Index

1992

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United Kingdom)

Novartis (United States)

Novartis (Italy)

Ghent University Hospital

Giovanni Della Cioppa is an author at Novartis (Switzerland) specializing in medicine, immunology, and asthma.

Top concepts

Publications per year

1992–2022

46

Publications

46

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

, , +9

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 822 citations · Full text

Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma

Stephen T. Holgate, Jean‐Louis Hébert, Jan Lötvall et al. · Clinical & Experimental Allergy · 2004 · 516 citations

Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease

Ronald Dahl, Louis A.P.M. Greefhorst, Dariusz Nowak et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 352 citations

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

Steven Black, Uwe Nicolay, Timo Vesikari et al. · The Pediatric Infectious Disease Journal · 2011 · 328 citations

Rows per page

1–5 of 46